 MELBOURNE, Australia, March 10, 2022 GLOBE NEWSWIRE -- Opthea Limited ASX:OPT, a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that Dr Megan Baldwin, the Companys Chief Executive Officer, will present at Oppenheimers 32nd Annual Healthcare Conference, being held virtually from March 15-17, 2022. 